Semaglutide and Cognition in Psychiatric Care: What a 13,007-Patient Cohort Found
semaglutide cognition psychiatric cohort: In a retrospective cohort of 13,007 adults with psychiatric diagnoses, semaglutide initiation was associated with fewer clinician-recorded cognitive signs over 12 months than no antidiabetic treatment, glipizide,…
Smoked Cannabis Across Potencies: What a Controlled Study Found About Sex Differences
smoked cannabis sex differences: A randomized human laboratory experiment exposed 35 adults to placebo and three smoked-cannabis potencies. Females and males reached similar blood THC concentrations and showed few consistent differences across…
Cannabinoids and Cognitive Function in Bipolar Disorder: What a New Study Found
A new study on cannabinoids cognition bipolar disorder examined whether cannabis use correlates with improved timing and attention in people with bipolar disorder. Chronic cannabis users performed similarly to healthy adults, and an acute THC challenge…
Exploring Histamine Brain Pathways in Psychiatric Disorders
This study on histamine brain pathways psychiatric disorders maps histamine-related genes across the human brain and their relation to cognition, emotion, and sleep. Findings suggest histamine plays a broad role in brain organization linked to…
Cannabinoids and cognition in Parkinson’s disease: Insights from animal models and emerging clinical evidence.
Parkinson's disease (PD) is a progressive, multisystem neurodegenerative disorder characterized not only by motor impairments but also by a broad spectrum of...
Understanding Cannabis Memory Effects: Clinical Relevance
Cannabis memory effects clinical relevance is a key concern for therapeutic users. Understanding how cannabis impacts memory helps guide safer dosing. This knowledge supports better patient counseling and safety.
Discrepancies between subjective and objective cognition in persons with multiple sclerosis: Exploring the role of cannabis use.
This study investigates cannabis cognitive effects multiple sclerosis patients experience, revealing discrepancies between subjective complaints and objective testing. Cannabis users with MS report greater perceived cognitive deficits than non-users.…